本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TFF Pharmaceuticals

0.0650
0.0000
成交量:- -
成交額:- -
市值:28.88萬
市盈率:-0.01
高:0.0650
開:0.0650
低:0.0650
收:0.0650
52周最高:0.0650
52周最低:0.0650
股本:444.30萬
流通股本:324.24萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-5.7837
每股收益(LYR):-11.8508
淨資產收益率:-220.13%
總資產收益率:-106.45%
市淨率:0.09
市盈率(LYR):-0.01

資料載入中...

2024/05/08

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/05/03

SEC問詢函

Form CORRESP - Correspondence
2024/05/02

重要事件披露

Form 8-K - Current report
2024/04/29

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/29

重要事件披露

Form 8-K - Current report
2024/04/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/18

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/08

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/28

重要事件披露

Form 8-K - Current report
2024/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/22

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/19

重要事件披露

Form 8-K - Current report
2023/12/16

重要事件披露

Form 8-K - Current report
2023/12/09

SEC問詢函

Form CORRESP - Correspondence
2023/12/08

重要事件披露

Form 8-K - Current report
2023/12/05

重要事件披露

Form 8-K - Current report